BioCentury
ARTICLE | Clinical News

Panzem NCD 2-methoxyestradiol: Interim Phase II data

February 4, 2008 8:00 AM UTC

Interim data from an open-label Phase II trial in 29 evaluable patients showed that Panzem NCD plus Avastin bevacizumab produced 27 cases of stable disease. Median follow-up time was >8 months. Media...